{"count": 1, "results": [{"_id": "19664625", "pmid": 19664625, "title": "Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation.", "journal": "Exp Neurol", "authors": ["Carloni S", "Girelli S", "Buonocore G", "Longini M", "Balduini W"], "date": "2009-11-01T00:00:00Z", "doi": "10.1016/j.expneurol.2009.07.026", "meta_date_publication": "2009 Nov", "meta_volume": "220", "meta_issue": "1", "meta_pages": "82-9", "score": 50066.82, "text_hl": "Neonatal @SPECIES_10116 @@@rats@@@ were subjected to @DISEASE_Arterial_Occlusive_Diseases @DISEASE_MESH:D001157 @@@occlusion of the@@@ right carotid @DISEASE_Renal_Artery_Obstruction @DISEASE_MESH:D012078 @@@artery@@@ followed by 2.5 h @DISEASE_Hypoxia @DISEASE_MESH:D000860 @@@hypoxia@@@ (@DISEASE_Hypoxia @DISEASE_MESH:D000860 @@@hypoxia@@@-@DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischemia@@@, @<m>DISEASE_Harlequin_type_ichthyosis</m> @DISEASE_MESH:C538424 @@@HI@@@). @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Sim@@@ was given at the dose of 10 or 5 mg/kg, s.c. from postnatal day 1 (PN1) to PN7, or at 20 mg/kg from PN4 to PN7, or at 20 mg/kg in a single administration 18 h before the onset of the @DISEASE_Brain_Ischemia @DISEASE_MESH:D002545 @@@ischemic@@@ procedure. ", "citations": {"NLM": "Carloni S, Girelli S, Buonocore G, Longini M, Balduini W. Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation. Exp Neurol. 2009 Nov;220(1):82-9. PMID: 19664625", "BibTeX": "@article{19664625, title={Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation.}, author={Carloni S and Girelli S and Buonocore G and Longini M and Balduini W}, journal={Exp Neurol}, volume={220}, number={1}, pages={82-9}}"}}]}